Literature DB >> 19047998

Should cisplatin be avoided in the treatment of locally advanced squamous cell carcinoma of the anal canal?

Cathy Eng1, Christopher H Crane, Miguel A Rodriguez-Bigas.   

Abstract

Entities:  

Year:  2008        PMID： 19047998     DOI： 10.1038/ncpgasthep1319

Source DB:  PubMed          Journal:  Nat Clin Pract Gastroenterol Hepatol        ISSN： 1743-4378


× No keyword cloud information.
  9 in total

Review 1.  Anal cancer: current and future methodology.

Authors:  Cathy Eng
Journal:  Cancer Invest       Date:  2006 Aug-Sep       Impact factor: 2.176

2.  Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. UKCCCR Anal Cancer Trial Working Party. UK Co-ordinating Committee on Cancer Research.

Authors: 
Journal:  Lancet       Date:  1996-10-19       Impact factor: 79.321

3.  Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups.

Authors:  H Bartelink; F Roelofsen; F Eschwege; P Rougier; J F Bosset; D G Gonzalez; D Peiffert; M van Glabbeke; M Pierart
Journal:  J Clin Oncol       Date:  1997-05       Impact factor: 44.544

4.  High-dose radiation therapy and neoadjuvant plus concomitant chemotherapy with 5-fluorouracil and cisplatin in patients with locally advanced squamous-cell anal canal cancer: final results of a phase II study.

Authors:  D Peiffert; M Giovannini; M Ducreux; P Michel; E François; C Lemanski; X Mirabel; F Cvitkovic; E Luporsi; T Conroy; J P Gérard
Journal:  Ann Oncol       Date:  2001-03       Impact factor: 32.976

5.  Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study.

Authors:  M Flam; M John; T F Pajak; N Petrelli; R Myerson; S Doggett; J Quivey; M Rotman; H Kerman; L Coia; K Murray
Journal:  J Clin Oncol       Date:  1996-09       Impact factor: 44.544

6.  Epidermoid anal cancer: treatment by radiation alone or by radiation and 5-fluorouracil with and without mitomycin C.

Authors:  B J Cummings; T J Keane; B O'Sullivan; C S Wong; C N Catton
Journal:  Int J Radiat Oncol Biol Phys       Date:  1991-10       Impact factor: 7.038

7.  Induction therapy for poor-prognosis anal canal carcinoma: a phase II study of the cancer and Leukemia Group B (CALGB 9281).

Authors:  Neal J Meropol; Donna Niedzwiecki; Brenda Shank; Thomas A Colacchio; John Ellerton; Frank Valone; Susan Budinger; Jeannette M Day; Judy Hopkins; Joel Tepper; Richard M Goldberg; Robert J Mayer
Journal:  J Clin Oncol       Date:  2008-05-19       Impact factor: 44.544

8.  Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992-2003.

Authors:  Pragna Patel; Debra L Hanson; Patrick S Sullivan; Richard M Novak; Anne C Moorman; Tony C Tong; Scott D Holmberg; John T Brooks
Journal:  Ann Intern Med       Date:  2008-05-20       Impact factor: 25.391

9.  Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trial.

Authors:  Jaffer A Ajani; Kathryn A Winter; Leonard L Gunderson; John Pedersen; Al B Benson; Charles R Thomas; Robert J Mayer; Michael G Haddock; Tyvin A Rich; Christopher Willett
Journal:  JAMA       Date:  2008-04-23       Impact factor: 56.272
  9 in total
  1 in total

1.  Anal cancer - a review.

Authors:  Sajad Ahmad Salati; Azzam Al Kadi
Journal:  Int J Health Sci (Qassim)       Date:  2012-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.